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a b s t r a c t
Paraneoplastic neurologic syndromes are diagnosed when neurologic symptoms are asso-
ciated with neoplasm and other causative factors are excluded. They may precede or be
simultaneous to various types of neoplasms, mainly malignant. In men up to 45–50 years old
the most common cancer causing the paraneoplastic syndrome is testicle tumor, manifest-
ing usually as limbic/brain stem encephalitis and myelitis. Usually effective treatment of
underlying neoplasm brings resolution of neurologic symptoms. But corticosteroids and
intravenuous immunoglobulins are also used. In the presented case a 37-year-old man was
primarily diagnosed and treated for progressive tetraparesis with signs of both upper and
lower motor neuron dysfunction, associated with bulbar symptoms. Having various diag-
nostic procedures performed an atypical form of chronic inﬂammatory demyelinating
polyradiculoneuronopathy was primarily suspected, but eventually a discovery of endoder-
mal sinus tumor in the testicle enabled to state the diagnosis of possible paraneoplastic
syndrome. In spite of chemotherapy the patient died shortly after the diagnosis because of
infectious complications. Histopathology displayed intense inﬂammatory changes in the
brain stem as well as in cranial nerves and cervical spinal cord. The same immunological
process evoked by various pathogenetic factors (infection vs. neoplasm) may cause similar
clinical picture and hinder the diagnosis. Most importantly it may delay the proper way of
treatment.
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Yolk sac tumor (YST) is a rare malignant germ cell tumor found
in the testis or ovary, and occasionally in extragonadal
location. Only single case reports have described the presence
of this tumor in the head, lung, stomach, liver, mediastinum,
peritoneum, kidney, prostate, vagina, vulva, and presacral
regions [1–4]. Like other cancers, YST may be associated with
paraneoplastic syndromes. The syndrome most commonly
related to YST and other germ-cell cancers of the testis is
paraneoplastic encephalitis. The association of the limbic/
brainstem encephalitis concurrent with the anti-Ma2 onco-
neural antibodies was widely described, as well as the
presence of testicular tumors as its causative factor in more
than 80% of patients, usually men younger than 45–50 years
old [5,6].
Paraneoplastic neurologic syndromes are diagnosed when
neurologic symptoms are associated with neoplasm and other
causative factors are excluded [5]. It is believed that they result
from an immune response to an antigen shared between the
cancer and the nervous system. They are rare, less than 1% of
all patients with various cancers suffer from such disorders.
However, depending on the kind of a cancer this may be as
high as 30% in small cell lung carcinoma [7,8]. The eight
paraneoplastic syndromes most likely to be associated with
cancer, the so called ‘‘classic’’ syndromes, include encephalo-
myelitis, limbic encephalitis, subacute cerebellar degenera-
tion, opsoclonus-myoclonus, subacute sensory neuronopathy,
chronic gastrointestinal pseudo-obstruction, Lambert–Eaton's
syndrome and dermatomyositis [5].
There are other neurologic syndromes such as acquired
neuromyotonia, motor neuron disease, stiff-men syndrome,
Guillain–Barré syndrome, and chronic inﬂammatory demye-
linating polyradiculopathy (CIDP) that may be the so-called
‘‘non-classic’’ paraneoplastic syndromes. They constitute a
peculiar diagnostic challenge.
We would like to present a case report of a patient with a
non-classic paraneoplastic syndrome or an overlap syndrome
associated with testicular germ-cell tumor.
2. Case report
Thirty-seven year-old man, physical worker and current
smoker, complained of progressive four-limb weakness (at
ﬁrst lower then upper limbs) followed by swallowing and
speech problems, which he attributed to the upper respiratory
tract infection that preceded symptoms by one month and was
treated with antibiotics.
First neurologic examination (in another hospital) revealed
triparesis – proximal in the right upper limb and distal in lower
limbs – with decreased muscle tone, but brisk reﬂexes, muscle
atrophy corresponding with the sites of paresis and bilateral
Babinski sign. Deep sensation in the lower limbs was disturbed
and bilateral Laseque's sign was noted. Involvement of cranial
nerves resulted in right-sided facial and tongue muscles
paresis, dysarthria and dysphagia.
Lumbar puncture revealed albuminocytologic dissociation
in the cerebrospinal ﬂuid (discreet cell count elevation of 14 ml,with preponderance of lymphocytes and monocytes and
almost threefold elevation of protein concentration of
129 mg/dl). Electrophysiology showed acute axonal-demyelin-
ating poliradiculoneuropathy of the motor ﬁbers with acute
denervation and reinervation in muscles. Performed twice MRI
scans of the brain with contrast enhancement were negative,
and central nervous system diseases such as boreliosis, herpes
simplex and HIV infections were excluded. Based on clinical
picture and results of additional tests the diagnosis of post-
inﬂammatory encephaloradiculoneuropathy was stated and
pharmacological treatment was introduced. Initially, high-
dose intravenous corticosteroids (1.0 g per day for ﬁve days of
methylprednisolone) were administered, and slight improve-
ment in the muscle strength was observed.
On admission to our clinic (four months later) further
aggravation of clinical symptoms was observed especially
considering bulbar symptoms (left abducens nerve palsy).
Treatment with intravenous immunoglobulin was started as
the second-line treatment (maximum dose of 2.0 g/kg body
weight), which again resulted in the improvement in muscle
strength and swallowing problems. Afterwards, long-term oral
therapy with prednisolone was initiated with the starting dose
of 1.3 mg/kg body weight and the patient was discharged
home. Meanwhile the neoplastic markers (AFP, total PSA, CEA,
CA-15-3, CA 19-9) were investigated as well as CT scans of the
chest and abdomen, and physical examination and USG of the
testis, but none showed abnormalities.
Three months after the ﬁrst one, the EMG investigation
showed pure axonal motor polyneuropathy.
Nearly one year later the patient was again admitted to our
clinic with deterioration of symptoms. This time external
ophtalmoparesis was notable (only vertical eye movements
were spared) and other cranial nerves damage of the bulbar
origin. Due to respiratory failure he needed non-invasive
mechanical ventilation by means of facial mask (Bi-level
Positive Airway Pressure). Once again the MRI scans of the
brain showed no abnormalities that could explain the
symptoms.
The patient informed on the left testicle swelling and pain
that he had consulted by urologist and had treated with
antibiotics for the last two months. Performed USG showed the
presence of a pathological mass in the left testicle suggestive
of a cancer. It was associated with the highly elevated alpha-
fetoprotein level in the blood (around 52 times upper limit).
The mass was surgically removed and the histopathology
investigation revealed yolk sack tumor with foci of embryonic
carcinoma. The patient underwent chemotherapy with cis-
platin and ethoposide. Unfortunately, shortly after the ﬁrst
course he developed severe leukopenia with agranulocytosis,
which was complicated by pneumonia and sepsis. The patient
eventually died.
The necropsy was performed. Post-mortem examination
revealed pneumonia but not metastases of the testis tumor.
Microscopic examination of the brain and spinal cord showed
inﬂammatory process involving both the central and periph-
eral nervous systems particularly severe in the brain stem,
cervical spinal cord and cranial nerves. The most evident
morphological manifestation of the inﬂammation was vascu-
litis involving small-sized arteries (Fig. 1A) and capillary
vessels. Inﬂammatory mononuclear cells inﬁltrating vessel
Fig. 1 – (A) Cuffs of the inflammatory infiltrates around small arteries in the posterior horn of the cervical spinal cord, H&E. (B)
CD3+ lymphocytes T within inflammatory infiltrate of the midbrain artery, anti-CD3. (C) Mononuclear cells around neurons
in the frontal cortex (arrows), H&E. (D) Numerous macrophages in the midbrain parenchyma; visible delicate perivascular
inflammatory infiltrates and well preserved neurons in the trochlear nerve nucleus, anti-ferritin
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lymphocytes T (Fig. 1B) while lymphocytes B were only
occasionally noted. Parenchymal lymphocytic inﬁltrates were
found in the brain stem, spinal cord, spinal roots as well as in
cranial nerves, particularly in the oculomotor nerve, but not in
the cerebral and cerebellar parenchyma. Although evident loss
of neurons was not observed in any of the examined
structures, increased perineuronal satelitosis and neurono-
phagy (Fig. 1C) were seen sporadically in the cerebral cortex
and basal ganglia. In the brain stem and spinal cord, microglia
activation and numerous macrophages accompanied the
inﬂammatory changes (Fig. 1D).
3. Discussion
Histopathologic investigation of the nervous system in the
patient with germ-cell tumor associated with inﬂammatory
encephaloradiculoneuropathy displayed paraneoplastic in-
ﬂammation of brain stem, spinal cord and cranial nerves.
The fact that the ﬁrst symptoms were preceded by the
upper respiratory tract infection probably delayed identiﬁca-
tion of the cancer, as the patient was presumed to present a
non-typical form of the chronic inﬂammatory demyelinating
polyneuropathy. His clinical presentation fulﬁlled the criteria
of the atypical CIDP according to EFNS/PNS guidelines
elaborated in 2010 [9]. A post-inﬂammatory beginning,
gradually progressing limb paresis and cranial nerve dysfunc-
tion supported this notion. Even though such symptoms like
bilateral Babinski sing and asymmetric limb paresis are not theusual presentation of this disease, similar cases in the
literature were described [9,10]. The diagnosis of CIDP was
supported by the presence of albuminocytologic dissociation
in cerebrospinal ﬂuid examination, axonal-demyelinating
damage to motor ﬁbers with assisting acute denervation
and reinervation features in EMG, and above all, by the lack of
changes in the brain MRI, specially scans of the brain stem and
limbic system, despite three investigations dispersed in time.
As a consequence a treatment with high-dose intravenous
methylprednisolone infusions were introduced followed by
intravenous human immunoglobulins (maximum dose of
2 mg/kg body weight fractioned in ﬁve portions). The treat-
ment resulted in slight regression of the symptoms and
temporary stabilization of the neurologic status.
Clinical picture suggestive of CIDP did not determine the
workup regarding neoplasmatic disorder. According to the
literature, it is highly uncommon for CIDP to be associated
with malignancy [11,12]. During the patient ﬁrst stay in our
clinic routine procedures including chest, abdomen and pelvis
examinations were performed. However, testicular germ-cell
tumor found during his second stay strongly suggests, that all
the demonstrated symptoms might have been the symptoms
of a paraneoplastic syndrome interfering with inﬂammatory
polyneuropathy.
According to the recommendations from 2004 elaborated
by PNS Euronetwork, if the non-typical paraneoplastic
syndrome with or without well-deﬁned onconeural antibodies
is followed by a diagnosis of the cancer within two years of
observation, it falls into a category of the certain paraneo-
plastic syndrome [5] (criteria of the certain and possible
Table 1 – Diagnostic criteria of the paraneoplastic syndrome (PNS).
Certain paraneoplastic syndrome
1 Classic PNSa + malignancy diagnosed within 5 years from PNS diagnosis
2 Non-classic PNS, which improves or resolves after neoplasm treatment, without immunotherapy being used; except – spontaneous PNS
remission
3 Non-classic PNS with positive onconeural antibodies (wellb or not well deﬁned) + malignancy diagnosed within 5 years from PNS diagnosis
4 Neurologic syndrome (classic or non-classic PNS) + positive well-characterised onconeural antibodies + no neoplasm
Possible paraneoplastic syndrome
1 Classic PNS + no onconeural antibodies + high risk of malignancy
2 Neurologic syndrome (classic PNS or not) + partially characterized onconeural antibodies + no malignancy
3 Non-classic PNS + no onconeural antibodies + malignancy diagnosed within 2 years after the PNS
a Classic PNS: encephalomyelitis, limbic encephalitis, subacute cerebellar atrophy, opsoclonus-myoclonus, subacute sensory neuronopathy,
chronic gastrointestinal pseudo-obstruction, Lambert–Eaton's syndrome, dermatomyositis.
b Well-characterized onconeural antibodies: anti-Hu, anti-Yo, anti-Ri, anti-CV2/CRMP5, anti-Ma/Ta, anti-amphiphisin.
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onconeural antibodies were investigated in this 37-year-old
man after the testis tumor had been found, as it was not
necessary for the diagnosis.
It is well known that the diagnosis of the paraneoplastic
syndrome poses a diagnostic challenge until the malignancy is
found. As six well-characterized onconeural antibodies have
rather high speciﬁcity (>90%) [13], they may help establishing
the diagnosis. On the other hand, they are found in only 50%
of the patients with PNS [5]. What is more, in up to 20% of
patients with classic paraneoplastic syndrome none of the
well-characterized onconeural antibodies is found.
Regarding our patient, it remains uncertain whether all
the symptoms present from the very beginning may have
resulted from the underlying paraneoplastic syndrome or
from inﬂammatory demyelinating polyradiculoneuropathy,
which later were joined by cross-link immunologic reaction to
cancer antigen. The fact that despite repeated brain MRI scans
no lesion of the brain stem and limbic system was found
neither exclude the diagnosis of the paraneoplastic syndrome
nor conﬁrm CIDP. Various studies showed that MRI changes
are found in 70–80% patients with paraneoplastic syndromes
[14] and in 20% of patients with CIDP [15,16]. EFNS Task Force
guidelines on management in PNS edited in 2006 [17] give the
value of 60% of patients with paraneoplastic limbic encepha-
litis and positive MRI investigation. But in the same time the
authors highlight the notion that using speciﬁc MRI imaging
such as FLAIR may result in the higher number of positive
results.
As a conclusion, clinical picture of the syndromes originat-
ing from immunologic reaction to various antigens (cancer vs.
infective agent antigens) may resemble each other and thus
signiﬁcantly hinder the process of establishing the proper
diagnosis.
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